Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.27) by 5.26 percent. This is a 22.22 percent increase over losses of $(0.36) per share from the same period last year.